285 related articles for article (PubMed ID: 20440589)
1. Targeting TRPV1 as an alternative approach to narcotic analgesics to treat chronic pain conditions.
Premkumar LS
AAPS J; 2010 Sep; 12(3):361-70. PubMed ID: 20440589
[TBL] [Abstract][Full Text] [Related]
2. Receptor and Molecular Targets for the Development of Novel Opioid and Non-Opioid Analgesic Therapies.
Chen R; Coppes OJM; Urman RD
Pain Physician; 2021 Mar; 24(2):153-163. PubMed ID: 33740349
[TBL] [Abstract][Full Text] [Related]
3. [Central and peripheral mechanisms in antinociception: current and future perspectives].
Fürst Z
Neuropsychopharmacol Hung; 2008 Jun; 10(3):127-30. PubMed ID: 18956616
[TBL] [Abstract][Full Text] [Related]
4. [Review of current pharmacologic treatment of pain].
Brasseur L
Drugs; 1997; 53 Suppl 2():10-7. PubMed ID: 9190320
[TBL] [Abstract][Full Text] [Related]
5. A patent review of transient receptor potential vanilloid type 1 modulators (2014-present).
Gao M; Wang Y; Liu L; Qiao Z; Yan L
Expert Opin Ther Pat; 2021 Feb; 31(2):169-187. PubMed ID: 33377418
[No Abstract] [Full Text] [Related]
6. The mechanism of μ-opioid receptor (MOR)-TRPV1 crosstalk in TRPV1 activation involves morphine anti-nociception, tolerance and dependence.
Bao Y; Gao Y; Yang L; Kong X; Yu J; Hou W; Hua B
Channels (Austin); 2015; 9(5):235-43. PubMed ID: 26176938
[TBL] [Abstract][Full Text] [Related]
7. Hot receptors in the brain.
Steenland HW; Ko SW; Wu LJ; Zhuo M
Mol Pain; 2006 Nov; 2():34. PubMed ID: 17092351
[TBL] [Abstract][Full Text] [Related]
8. Receptome: Interactions between three pain-related receptors or the "Triumvirate" of cannabinoid, opioid and TRPV1 receptors.
Zádor F; Wollemann M
Pharmacol Res; 2015 Dec; 102():254-63. PubMed ID: 26520391
[TBL] [Abstract][Full Text] [Related]
9. Modulation of the TRPV1 channel: current clinical trials and recent patents with focus on neurological conditions.
De Petrocellis L; Moriello AS
Recent Pat CNS Drug Discov; 2013 Dec; 8(3):180-204. PubMed ID: 24330123
[TBL] [Abstract][Full Text] [Related]
10. Biased Opioid Ligands.
Faouzi A; Varga BR; Majumdar S
Molecules; 2020 Sep; 25(18):. PubMed ID: 32948048
[TBL] [Abstract][Full Text] [Related]
11. Targeted nanoparticles that mimic immune cells in pain control inducing analgesic and anti-inflammatory actions: a potential novel treatment of acute and chronic pain condition.
Hua S; Cabot PJ
Pain Physician; 2013; 16(3):E199-216. PubMed ID: 23703419
[TBL] [Abstract][Full Text] [Related]
12. [Development of opioid tolerance -- molecular mechanisms and clinical consequences].
Freye E; Latasch L
Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Jan; 38(1):14-26. PubMed ID: 12522725
[TBL] [Abstract][Full Text] [Related]
13. Design and characterization of a noncompetitive antagonist of the transient receptor potential vanilloid subunit 1 channel with in vivo analgesic and anti-inflammatory activity.
García-Martínez C; Fernández-Carvajal A; Valenzuela B; Gomis A; Van Den Nest W; Ferroni S; Carreño C; Belmonte C; Ferrer-Montiel A
J Pain; 2006 Oct; 7(10):735-46. PubMed ID: 17018334
[TBL] [Abstract][Full Text] [Related]
14. Side Effects of Opioids Are Ameliorated by Regulating TRPV1 Receptors.
Wang X; Bao C; Li Z; Yue L; Hu L
Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206575
[TBL] [Abstract][Full Text] [Related]
15. Antinociceptive effect of hydroalcoholic extract and isoflavone isolated from Polygala molluginifolia in mice: evidence for the involvement of opioid receptors and TRPV1 and TRPA1 channels.
Nucci-Martins C; Nascimento LF; Venzke D; Brethanha LC; Sako AV; Oliveira AS; Brighente IM; Micke GA; Pizzolatti MG; Santos AR
Phytomedicine; 2016 May; 23(5):429-40. PubMed ID: 27064002
[TBL] [Abstract][Full Text] [Related]
16. Opioid and adjuvant analgesics: compared and contrasted.
Khan MI; Walsh D; Brito-Dellan N
Am J Hosp Palliat Care; 2011 Aug; 28(5):378-83. PubMed ID: 21622486
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: Recent advances and setbacks.
Wong GY; Gavva NR
Brain Res Rev; 2009 Apr; 60(1):267-77. PubMed ID: 19150372
[TBL] [Abstract][Full Text] [Related]
18. [Neurochemical analysis and pharmacological regulation of the corticofugal control of the nociceptive signals in the afferent pathways].
Churiukanov VV
Eksp Klin Farmakol; 2003; 66(2):24-31. PubMed ID: 12962044
[TBL] [Abstract][Full Text] [Related]
19. Opioids and TRPV1 in the peripheral control of neuropathic pain--Defining a target site in the injured nerve.
Labuz D; Spahn V; Celik MÖ; Machelska H
Neuropharmacology; 2016 Feb; 101():330-40. PubMed ID: 26453963
[TBL] [Abstract][Full Text] [Related]
20. TRPV1 promotes opioid analgesia during inflammation.
Basso L; Aboushousha R; Fan CY; Iftinca M; Melo H; Flynn R; Agosti F; Hollenberg MD; Thompson R; Bourinet E; Trang T; Altier C
Sci Signal; 2019 Apr; 12(575):. PubMed ID: 30940767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
